Cooley represents drug maker Alvotech on its $2.25 bln SPAC deal
Alvotech Holdings SA tapped Cooley to advise it on its blank-check merger, which will create a pharmaceutical company worth roughly $2.25 billion.
Source: reuters.com
Stay updated with breaking news from Div Gupta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alvotech Holdings SA tapped Cooley to advise it on its blank-check merger, which will create a pharmaceutical company worth roughly $2.25 billion.